PATENT CLAIM ANALYSIS

Application Number: 15895279
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "207000"]

Abstract:
Pharmaceutical compositions are provided in unit dosage forms comprising ceftolozane and tazobactam in separate unit dosage form containers, ceftolozane prepared in the absence of tazobactam, tazobactam prepared in the absence of ceftolozane, and/or compositions where ceftolozane and tazobactam are first combined within a unit dosage form container.

Claim (Index 1):
A unit dosage form package comprising a unit dosage form container enclosing a ceftolozane composition, the unit dosage form package manufactured by a process comprising the steps of:\n a. lyophilizing a solution comprising ceftolozane sulfate and about 125 mg to about 500 mg sodium chloride per 1,000 mg of ceftolozane active in the solution to obtain a lyophilized ceftolozane composition prepared in the absence of tazobactam; b. first contacting the lyophilized ceftolozane composition with a tazobactam composition within a unit dosage form container, where the tazobactam composition comprises tazobactam; and c. enclosing the lyophilized ceftolozane composition and the tazobactam composition together within the unit dosage form container.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.82143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15071530', '14214221', '14285185', '15844961', '14856075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7885456018432494
- 35 USC 102 Novelty (BERT): 0.6388671467974315
- Combined Prediction Score: 0.7735777563386677
- Mean Citation Score: 540.2332100000001
- Max Citation Score: 644.7732
- Similarity Product: 544.6088557552814

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test